Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MDMA-assisted psychotherapy for PTSD in veterans and first responders
ACTRN12623000971639Phase 2Recruiting
- Sponsor
- Monash University
- Start
- Nov 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, single-blind trial of midomafetamine in post-traumatic stress disorder (PTSD) (2 arms), sponsored by Monash University. Primary endpoint: Mean group difference in PTSD symptom severity. Started Nov 2023; status: recruiting.
02
Drugs
midomafetamine
03
Conditions
post-traumatic stress disorder (PTSD)
Beyond the preview
Go deeper on ACTRN12623000971639.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12623000971639.